193 related articles for article (PubMed ID: 22343504)
1. 11C-Acetate PET/CT in localized prostate cancer: a study with MRI and histopathologic correlation.
Mena E; Turkbey B; Mani H; Adler S; Valera VA; Bernardo M; Shah V; Pohida T; McKinney Y; Kwarteng G; Daar D; Lindenberg ML; Eclarinal P; Wade R; Linehan WM; Merino MJ; Pinto PA; Choyke PL; Kurdziel KA
J Nucl Med; 2012 Apr; 53(4):538-45. PubMed ID: 22343504
[TBL] [Abstract][Full Text] [Related]
2. Localized prostate cancer detection with 18F FACBC PET/CT: comparison with MR imaging and histopathologic analysis.
Turkbey B; Mena E; Shih J; Pinto PA; Merino MJ; Lindenberg ML; Bernardo M; McKinney YL; Adler S; Owenius R; Choyke PL; Kurdziel KA
Radiology; 2014 Mar; 270(3):849-56. PubMed ID: 24475804
[TBL] [Abstract][Full Text] [Related]
3. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
4. Is there an additional value of ¹¹C-choline PET-CT to T2-weighted MRI images in the localization of intraprostatic tumor nodules?
Van den Bergh L; Koole M; Isebaert S; Joniau S; Deroose CM; Oyen R; Lerut E; Budiharto T; Mottaghy F; Bormans G; Van Poppel H; Haustermans K
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1486-92. PubMed ID: 22284686
[TBL] [Abstract][Full Text] [Related]
5. [
Bauman G; Martin P; Thiessen JD; Taylor R; Moussa M; Gaed M; Rachinsky I; Kassam Z; Chin J; Pautler S; Lee TY; Valliant JF; Ward A
Eur Urol Focus; 2018 Sep; 4(5):702-706. PubMed ID: 28753797
[TBL] [Abstract][Full Text] [Related]
6. Detection of recurrent prostate cancer after radical prostatectomy: comparison of 11C-choline PET/CT with pelvic multiparametric MR imaging with endorectal coil.
Kitajima K; Murphy RC; Nathan MA; Froemming AT; Hagen CE; Takahashi N; Kawashima A
J Nucl Med; 2014 Feb; 55(2):223-32. PubMed ID: 24434294
[TBL] [Abstract][Full Text] [Related]
7. Multiparametric [11C]Acetate positron emission tomography-magnetic resonance imaging in the assessment and staging of prostate cancer.
Polanec SH; Andrzejewski P; Baltzer PAT; Helbich TH; Stiglbauer A; Georg D; Karanikas G; Susani M; Wadsak W; Margreiter M; Mitterhauser M; Brader P; Pinker K
PLoS One; 2017; 12(7):e0180790. PubMed ID: 28719629
[TBL] [Abstract][Full Text] [Related]
8. 18F-DCFBC Prostate-Specific Membrane Antigen-Targeted PET/CT Imaging in Localized Prostate Cancer: Correlation With Multiparametric MRI and Histopathology.
Turkbey B; Mena E; Lindenberg L; Adler S; Bednarova S; Berman R; Ton AT; McKinney Y; Eclarinal P; Hill C; Afari G; Bhattacharyya S; Mease RC; Merino MJ; Jacobs PM; Wood BJ; Pinto PA; Pomper MG; Choyke PL
Clin Nucl Med; 2017 Oct; 42(10):735-740. PubMed ID: 28806263
[TBL] [Abstract][Full Text] [Related]
9. Does 11C-choline PET-CT contribute to multiparametric MRI for prostate cancer localisation?
Van den Bergh L; Isebaert S; Koole M; Oyen R; Joniau S; Lerut E; Deroose CM; De Keyzer F; Van Poppel H; Haustermans K
Strahlenther Onkol; 2013 Sep; 189(9):789-95. PubMed ID: 23797481
[TBL] [Abstract][Full Text] [Related]
10. Comparison of
Zamboglou C; Drendel V; Jilg CA; Rischke HC; Beck TI; Schultze-Seemann W; Krauss T; Mix M; Schiller F; Wetterauer U; Werner M; Langer M; Bock M; Meyer PT; Grosu AL
Theranostics; 2017; 7(1):228-237. PubMed ID: 28042330
[TBL] [Abstract][Full Text] [Related]
11. Prospective Study of the Radiolabeled GRPR Antagonist BAY86-7548 for Positron Emission Tomography/Computed Tomography Imaging of Newly Diagnosed Prostate Cancer.
Touijer KA; Michaud L; Alvarez HAV; Gopalan A; Kossatz S; Gonen M; Beattie B; Sandler I; Lyaschenko S; Eastham JA; Scardino PT; Hricak H; Weber WA
Eur Urol Oncol; 2019 Mar; 2(2):166-173. PubMed ID: 31017093
[TBL] [Abstract][Full Text] [Related]
12. Voxel-wise correlation of positron emission tomography/computed tomography with multiparametric magnetic resonance imaging and histology of the prostate using a sophisticated registration framework.
Reynolds HM; Williams S; Jackson P; Mitchell C; Hofman MS; Hicks RJ; Murphy DG; Haworth A
BJU Int; 2019 Jun; 123(6):1020-1030. PubMed ID: 30536698
[TBL] [Abstract][Full Text] [Related]
13. Investigation on tumor hypoxia in resectable primary prostate cancer as demonstrated by 18F-FAZA PET/CT utilizing multimodality fusion techniques.
Garcia-Parra R; Wood D; Shah RB; Siddiqui J; Hussain H; Park H; Desmond T; Meyer C; Piert M
Eur J Nucl Med Mol Imaging; 2011 Oct; 38(10):1816-23. PubMed ID: 21833840
[TBL] [Abstract][Full Text] [Related]
14. Improved detection of localized prostate cancer using co-registered MRI and 11C-acetate PET/CT.
Jambor I; Borra R; Kemppainen J; Lepomäki V; Parkkola R; Dean K; Alanen K; Arponen E; Nurmi M; Aronen HJ; Minn H
Eur J Radiol; 2012 Nov; 81(11):2966-72. PubMed ID: 22342610
[TBL] [Abstract][Full Text] [Related]
15. ¹⁸F-DCFBC PET/CT for PSMA-Based Detection and Characterization of Primary Prostate Cancer.
Rowe SP; Gage KL; Faraj SF; Macura KJ; Cornish TC; Gonzalez-Roibon N; Guner G; Munari E; Partin AW; Pavlovich CP; Han M; Carter HB; Bivalacqua TJ; Blackford A; Holt D; Dannals RF; Netto GJ; Lodge MA; Mease RC; Pomper MG; Cho SY
J Nucl Med; 2015 Jul; 56(7):1003-1010. PubMed ID: 26069305
[TBL] [Abstract][Full Text] [Related]
16. [11C]Acetate positron emission tomography-computed tomography imaging of prostate cancer lymph-node metastases correlated with histopathological findings after extended lymphadenectomy.
Schumacher MC; Radecka E; Hellström M; Jacobsson H; Sundin A
Scand J Urol; 2015 Feb; 49(1):35-42. PubMed ID: 25001948
[TBL] [Abstract][Full Text] [Related]
17. Imaging prostate cancer with 11C-choline PET/CT.
Reske SN; Blumstein NM; Neumaier B; Gottfried HW; Finsterbusch F; Kocot D; Möller P; Glatting G; Perner S
J Nucl Med; 2006 Aug; 47(8):1249-54. PubMed ID: 16883001
[TBL] [Abstract][Full Text] [Related]
18. 11C-acetate positron emission tomography imaging and image fusion with computed tomography and magnetic resonance imaging in patients with recurrent prostate cancer.
Wachter S; Tomek S; Kurtaran A; Wachter-Gerstner N; Djavan B; Becherer A; Mitterhauser M; Dobrozemsky G; Li S; Pötter R; Dudczak R; Kletter K
J Clin Oncol; 2006 Jun; 24(16):2513-9. PubMed ID: 16636343
[TBL] [Abstract][Full Text] [Related]
19. Prospective evaluation of
Jambor I; Kuisma A; Kähkönen E; Kemppainen J; Merisaari H; Eskola O; Teuho J; Perez IM; Pesola M; Aronen HJ; Boström PJ; Taimen P; Minn H
Eur J Nucl Med Mol Imaging; 2018 Mar; 45(3):355-364. PubMed ID: 29147764
[TBL] [Abstract][Full Text] [Related]
20. 11C-acetate PET/CT before radical prostatectomy: nodal staging and treatment failure prediction.
Haseebuddin M; Dehdashti F; Siegel BA; Liu J; Roth EB; Nepple KG; Siegel CL; Fischer KC; Kibel AS; Andriole GL; Miller TR
J Nucl Med; 2013 May; 54(5):699-706. PubMed ID: 23471311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
